These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3328998)

  • 1. [Development of therapeutic strategies in infertility of the couple].
    Zorn JR; Rolet F; Boyer P; Guichard A; Cedard L; Sureau C
    Bull Acad Natl Med; 1987 Oct; 171(7):837-40. PubMed ID: 3328998
    [No Abstract]   [Full Text] [Related]  

  • 2. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of GnRH antagonists in ovarian stimulation for intrauterine inseminations: is there any interest?].
    Pasquier M; Maitrot L; Leperlier F; Dehghani C; Snaifer E; Durnerin IC; Hugues JN
    Gynecol Obstet Fertil; 2008 Jun; 36(6):644-9. PubMed ID: 18539072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intrauterine insemination: state-of-the-art in humans].
    Royère D
    Gynecol Obstet Fertil; 2004 Oct; 32(10):873-9. PubMed ID: 15501166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery for in vitro fertilization: rationale, current strategies and challenges.
    Janát-Amsbury MM; Gupta KM; Kablitz CD; Peterson CM
    Adv Drug Deliv Rev; 2009 Aug; 61(10):871-82. PubMed ID: 19426774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ART of assisted reproductive technology.
    Persson J
    Aust Fam Physician; 2005 Mar; 34(3):119-22. PubMed ID: 15799656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IVF therapy for unexplained infertility.
    Harrison EC; Taylor JS
    Am Fam Physician; 2006 Jan; 73(1):63-5. PubMed ID: 16417064
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic insemination as 1 of the methods of treating marital infertility (a review of the literature)].
    Borshch IuG; Sol'skiĭ IaP
    Pediatr Akus Ginekol; 1978; (1):47-9. PubMed ID: 345203
    [No Abstract]   [Full Text] [Related]  

  • 9. Unexplained subfertility: a pragmatic approach.
    El-Toukhy TA
    J Obstet Gynaecol; 2002 May; 22(3):239-42. PubMed ID: 12521491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate methods to monitor controlled ovarian hyperstimulation?
    Cebesoy FB
    Fertil Steril; 2008 Apr; 89(4):1025; author reply 1025-6. PubMed ID: 18325501
    [No Abstract]   [Full Text] [Related]  

  • 11. Endometrial thickness is related to miscarriage rate, but not to the estradiol concentration, in cycles down-regulated with gonadotropin-releasing hormone antagonist.
    Detti L; Yelian FD; Kruger ML; Diamond MP; Rode A; Mitwally MF; Puscheck EE
    Fertil Steril; 2008 Apr; 89(4):998-1001. PubMed ID: 17678904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations of good practice: medicines that induce ovulation (June 2003)].
    AFSSAPS
    Gynecol Obstet Fertil; 2003; 31(7-8):676-86. PubMed ID: 14563614
    [No Abstract]   [Full Text] [Related]  

  • 13. Ovulation induction in the era of recombinant gonadotropins and GnRH analogues.
    Insler V; Lunenfeld B
    Isr J Med Sci; 1996 Feb; 32(2):79-89. PubMed ID: 8631655
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intrauterine insemination, indications, and results].
    Le Lannou D
    Contracept Fertil Sex; 1994 Jun; 22(6):361-9. PubMed ID: 8075650
    [No Abstract]   [Full Text] [Related]  

  • 15. Consensus on infertility treatment related to polycystic ovary syndrome.
    Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
    Hum Reprod; 2008 Mar; 23(3):462-77. PubMed ID: 18308833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists.
    Rabinson J; Ashkenazi J; Homburg R; Meltcer S; Anteby EY; Orvieto R
    Fertil Steril; 2009 Apr; 91(4 Suppl):1473-5. PubMed ID: 18937940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended induction of ovulation by human menopausal gonadotropins and a gonadotropin-releasing hormone analog in high responders for in vitro fertilization and oocyte donation.
    Amit A; Yaron Y; Azem F; Peyser MR; David MP; Lessing JB
    J Reprod Med; 1995 Sep; 40(9):633-7. PubMed ID: 8576879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Induction of ovulation: Comparative study on the response of the ovary to the treatment with human gonadotropins, synthetic hypothalamic gonadotropin-releasing hormone (LH-RH) and nonhormonal agents (clomiphene, cyclophenyl, etc). Therapeutic studies on the treatment of anovulatory sterility].
    Zañartu J; Dabancens A; Rodríguez-Bravo R; Schally AV
    Rev Chil Obstet Ginecol; 1973; 38(5):240-51. PubMed ID: 4619840
    [No Abstract]   [Full Text] [Related]  

  • 19. Current management of unexplained infertility.
    Stovall DW; Guzick DS
    Curr Opin Obstet Gynecol; 1993 Apr; 5(2):228-33. PubMed ID: 8490093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
    Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.